Aura Biosciences Stock Today
| AURA Stock | USD 7.16 0.21 3.02% |
Performance0 of 100
| Odds Of DistressLess than 22
|
Aura Biosciences is trading at 7.16 as of the 22nd of May 2024, a 3.02% increase since the beginning of the trading day. The stock's open price was 6.95. Aura Biosciences has about a 22 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Aura Biosciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 22nd of February 2024 and ending today, the 22nd of May 2024. Click here to learn more.
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts. Aura Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 49.54 M outstanding shares of which 2.76 M shares are presently shorted by private and institutional investors with about 23.8 trading days to cover. More on Aura Biosciences
Moving against Aura Stock
| 0.72 | YS | YS Biopharma | PairCorr |
| 0.62 | VALN | Valneva SE ADR | PairCorr |
| 0.54 | VERU | Veru Inc Fiscal Year End 13th of December 2024 | PairCorr |
| 0.45 | DOMH | Dominari Holdings | PairCorr |
Aura Biosciences cannot be verified against its exchange. It appears that Aura Biosciences is not available for investing at the moment. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
RefreshAura Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Aura Biosciences' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Aura Biosciences or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Pharmaceutical Products, Biotechnology, Healthcare, Stock Exchange Of, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Aura Biosciences (AURA) is traded on NASDAQ Exchange in USA. It is located in 80 Guest Street, Boston, MA, United States, 02135 and employs 88 people. Aura Biosciences is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 344.33 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aura Biosciences's market, we take the total number of its shares issued and multiply it by Aura Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Aura Biosciences conducts business under Biotechnology sector and is part of Health Care industry. The entity has 49.54 M outstanding shares of which 2.76 M shares are presently shorted by private and institutional investors with about 23.8 trading days to cover.
Aura Biosciences currently holds about 122.13 M in cash with (63.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.17.
Check Aura Biosciences Probability Of Bankruptcy
Aura Biosciences Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Aura Biosciences market risk premium is the additional return an investor will receive from holding Aura Biosciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Aura Biosciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Aura Biosciences' alpha and beta are two of the key measurements used to evaluate Aura Biosciences' performance over the market, the standard measures of volatility play an important role as well.
| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.42) | |||
| Total Risk Alpha | (0.64) | |||
| Treynor Ratio | (0.13) |
Aura Stock Against Markets
Picking the right benchmark for Aura Biosciences stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Aura Biosciences stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Aura Biosciences is critical whether you are bullish or bearish towards Aura Biosciences at a given time. Please also check how Aura Biosciences' historical prices are related to one of the top price index indicators.
Try Other Suggestions
Be your own money manager
Our tools can tell you how much better you can do entering a position in Aura Biosciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Money Flow Index Now
Money Flow IndexDetermine momentum by analyzing Money Flow Index and other technical indicators |
| All Next | Launch Module |
Aura Biosciences Corporate Management
Elected by the shareholders, the Aura Biosciences' board of directors comprises two types of representatives: Aura Biosciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aura. The board's role is to monitor Aura Biosciences' management team and ensure that shareholders' interests are well served. Aura Biosciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aura Biosciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Richard Mountfield | Senior Quality | Profile | |
| Patrick Nealon | Senior Operations | Profile | |
| CPE MBA | Chief RD | Profile | |
| Jill MD | Chief Development | Profile | |
| Paulo Carvalho | VP Operations | Profile | |
| Bruce MD | Senior Oncology | Profile |
How to buy Aura Stock?
Before investing in Aura Biosciences, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Aura Biosciences. To buy Aura Biosciences stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Aura Biosciences. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Aura Biosciences stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Aura Biosciences stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Aura Biosciences stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Aura Biosciences, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Aura Stock please use our How to Invest in Aura Biosciences guide.
Already Invested in Aura Biosciences?
The danger of trading Aura Biosciences is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Aura Biosciences is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Aura Biosciences. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Aura Biosciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Aura Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aura Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aura Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aura Biosciences Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aura Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Aura Stock refer to our How to Trade Aura Stock guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for Aura Stock analysis
When running Aura Biosciences' price analysis, check to measure Aura Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aura Biosciences is operating at the current time. Most of Aura Biosciences' value examination focuses on studying past and present price action to predict the probability of Aura Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aura Biosciences' price. Additionally, you may evaluate how the addition of Aura Biosciences to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
Is Aura Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aura Biosciences. If investors know Aura will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aura Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Aura Biosciences is measured differently than its book value, which is the value of Aura that is recorded on the company's balance sheet. Investors also form their own opinion of Aura Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Aura Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aura Biosciences' market value can be influenced by many factors that don't directly affect Aura Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aura Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aura Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aura Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.